Other

Gilead Sciences·Income Statement·28 metrics

Breakdown

Loading...

Metrics

Capital Expenditures

Change in Accounts Receivable

Deferred taxes

Depreciation

Accounts payable

Increase (Decrease) in Accounts Receivable

Accrued liabilities

Income taxes

Increase (Decrease) in Inventories

Increase (Decrease) in Prepaid Expense and Other Assets

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Operating Activity, Including Discontinued Operation

Other Noncash Income (Expense)

Payment for (Proceeds from) Other Investing Activity

Payments for Repurchase of Common Stock

Payments of Dividends

Payments to Acquire Debt Securities, Available-for-Sale

Payments to Acquire Businesses, Net of Cash Acquired

Payments to Acquire Property, Plant, and Equipment

Proceeds from Issuance of Common Stock

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale

Financing — other

Sale of investments

Repayments of Debt

Research and development expense

Revenue

Stock-based compensation